Hepatitis B Community
7.17k Members
Avatar universal

Johnson & Johnson acquired Novira Therapeutics

Johnson & Johnson announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.  The acquisition includes Novira's portfolio of novel antivirals, including its lead candidate, NVR 3-778.  Financial terms of the transaction have not been disclosed.


More and More competition its always good. what do you thing of novira's NVR 3-778? do you think it might contribute to a final cure?
2 Responses
Avatar universal
Havent read the link the only way to determine weather its good or not is dependant on which direction johnson and johnson take the company only time will really tell
Avatar universal
i think still they are in phase "Produces Deep and Durable Knockdown" so they are far from contributing a cure.
Have an Answer?
Didn't find the answer you were looking for?
Ask a question
Popular Resources
For people with Obsessive-Compulsive Disorder (OCD), the COVID-19 pandemic can be particularly challenging.
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Here’s how your baby’s growing in your body each week.
These common ADD/ADHD myths could already be hurting your child
This article will tell you more about strength training at home, giving you some options that require little to no equipment.
In You Can Prevent a Stroke, Dr. Joshua Yamamoto and Dr. Kristin Thomas help us understand what we can do to prevent a stroke.